A tipping point in drug dosing in late-life schizophrenia

Takashi Tsuboi, Takefumi Suzuki, Hiroyuki Uchida

研究成果: Review article

3 引用 (Scopus)

抜粋

Minimally effective doses of antipsychotics are likely influenced by several clinical and demographic characteristics of patients, with age being one of the most important elements. In light of age-related physiologic changes as well as interindividual differences in pharmacokinetic and pharmacodynamic systems, individualized dosing with regard to age will be critically important for safer drug treatment for older patients with schizophrenia. In the present review, we propose the following cautious psychopharmacologic interventions for this population: 1) simple regimen (avoid polypharmacy), 2) be aware of the presence of patients who are very sensitive to drugs, 3) gradual dose titration, and 4) timely and thorough assessments of therapeutic and side effects. The age-related antipsychotic sensitivity highlights the importance of finding the lowest possible effective dose of antipsychotic drugs as patients with schizophrenia age to maximize therapeutic effects and minimize side effects.

元の言語English
ページ(範囲)225-233
ページ数9
ジャーナルCurrent Psychiatry Reports
13
発行部数3
DOI
出版物ステータスPublished - 2011 6 1

ASJC Scopus subject areas

  • Psychiatry and Mental health

フィンガープリント A tipping point in drug dosing in late-life schizophrenia' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用